Citation

Williamson DS, Smith GP, Mikkelsen GK, Jensen T, Acheson-Dossang P, Badolo L, Bedford ST, Chell V, Chen IJ, Dokurno P, Hentzer M, Newland S, Ray SC, Shaw T, Surgenor AE, Terry L, Wang Y, Christensen KV.: Design and Synthesis of Pyrrolo[2,3-<i>d</i>]pyrimidine-Derived Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Checkpoint Kinase 1 (CHK1)-Derived Crystallographic Surrogate. J Med Chem, Volume 64 (14), 2021

Authors

Acheson-Dossang P, Badolo L, Bedford ST, Chell V, Chen IJ, Christensen KV., Dokurno P, Hentzer M, Jensen T, Mikkelsen GK, Newland S, Ray SC, Shaw T, Smith GP, Surgenor AE, Terry L, Wang Y, Williamson DS

Journal

J Med Chem

Year

2021

DOI

10.1021/acs.jmedchem.1c00720

PubMed

34184879

Machine-readable

REST APIRDF